FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...
This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...
Chinese authorities defended the quality of homegrown generic medicines after groups of doctors complained of their efficacy ...
At the 63rd Annual Day Celebrations of the Indian Drug Manufacturers Association (IDMA) in Mumbai recently, Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), delivered a compelling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results